Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+1.02%
FTSE
0.00%
N225
+0.06%
AXJO
+0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
286.12M
Dividend Yield
0.00%
P/E Ratio
-15.10
EPS
-0.11
Revenue
201.32M
Avg. Volume
954.65K

Recently from Cashu

publisher logo
Cashu

Cerus Enhances Blood Safety with ADVANCED INTERCEPT System Technology for Transfusion Security

2 days ago
publisher logo
Cashu

Cerus Corporation: Overview and Key Developments in Blood Safety Solutions

4 days ago
publisher logo
Cashu

Cerus Corporation: Leading Innovation in Blood Safety with INTERCEPT Blood System

5 months ago

About

What does CERS do?
Cerus, headquartered in Concord, California, focuses on developing the INTERCEPT Blood System to enhance blood safety by reducing pathogens in transfusion blood components. The company employs 288 people and specializes in various blood products.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Website
http://www.cerus.com
Stocks
Health Care
cers
Cerus
CERS
-0.02 (-1.28%)
1.54
USD
At close at Jul 04, 20:35 UTC
Summary
News
Signals
Benchmarks
Financials